Bristol-Myers Squibb Company (BMY) Insider Trading
- $16,431,049.03
- $516,811,825.82
- Aug. 2, 2025
- Lamberto Andreotti
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 31, 2013 | Insider | 10,538 | $47.06 | Sell | $495,918.28 | |
| May 30, 2013 | EVP | 22,000 | $47.00 | Sell | $1,034,000.00 | |
| May 30, 2013 | Insider | 68,087 | $123.58 | Sell | $8,414,191.46 | |
| May 29, 2013 | Director | 1,000 | $123.72 | Buy | $123,720.00 | |
| May 28, 2013 | Insider | 32,959 | $124.91 | Sell | $4,116,908.69 | |
| May 28, 2013 | CFO | 25,000 | $48.68 | Sell | $1,217,000.00 | |
| May 28, 2013 | Director | 100,000 | $47.61 | Sell | $4,761,000.00 | |
| May 23, 2013 | EVP | 96,000 | $46.99 | Sell | $4,511,040.00 | |
| May 23, 2013 | Insider | 26,647 | $46.29 | Sell | $1,233,489.63 | |
| May 17, 2013 | Director | 225,996 | $42.99 | Sell | $9,715,568.04 | |
| May 8, 2013 | Director | 20,000 | $39.85 | Sell | $797,000.00 | |
| May 2, 2013 | Director | 20,000 | $39.76 | Sell | $795,200.00 | |
| April 11, 2013 | Director | 20,000 | $41.15 | Sell | $823,000.00 | |
| March 13, 2013 | SVP | 3,409 | $38.51 | Sell | $131,280.59 | |
| March 13, 2013 | Director | 20,000 | $38.18 | Sell | $763,600.00 | |
| Feb. 27, 2013 | Insider | 12,150 | $37.08 | Sell | $450,522.00 | |
| Feb. 26, 2013 | Director | 20,000 | $36.58 | Sell | $731,600.00 | |
| Jan. 17, 2013 | Director | 20,000 | $34.33 | Sell | $686,600.00 | |
| Dec. 28, 2012 | Director | 20,000 | $32.06 | Sell | $641,200.00 | |
| Oct. 3, 2012 | Director | 20,000 | $33.71 | Sell | $674,200.00 | |
| Aug. 10, 2012 | Director | 10,000 | $31.81 | Sell | $318,100.00 |
Insiders are both buying and selling Bristol-Myers Squibb Company stock.
The insider traders at Bristol-Myers Squibb Company are: Lamberto Andreotti, Gilla Kaplan, Giovanni Caforio, James M Cornelius, Rupert Vessey, Sandra Leung, Ernest Mario, Michael D Casey, Joseph C Caldarella, James J Loughlin, Louis S Schmukler, Autenried Paul Von, Robert J Hugin, Theodore R Samuels II, John E Elicker, Ann Powell, Samuel J Moed, Charles A Bancroft, Beatrice J Cazala, Adam Dubow, Christopher S Boerner, Mark J Alles, Michael A Friedman, Samit Hirawat, Dinesh C Paliwal, Richard W Barker, Joseph Eid, Karen Murphy Santiago, Lewis B Campbell, David V Elkins, Thomas O Daniel, Michael D. Casey, Joseph Caldarella, Terrie Curran, Perry A Karsen, James Cornelius, Francis M Cuss, Louis Schmukler, Robert M Plenge, Charles Bancroft, Carrie Smith Cox, Benjamin Hickey, Bartie Wendy Short, John H Weiland, John Elicker, Francis Cuss, Elliot Sigal, Lawrence Stein, Lawrence V Stein, Lewis Campbell, Thomas Daniel, Thomas J Jr. Lynch, Michael Casey, Michael W Bonney, Perry Karsen, Phil M Holzer, Robert J Bertolini, and Corp /De/ Celgene
The most active insider trader at Bristol-Myers Squibb Company is Lamberto Andreotti with 27 trades.
Robert J Hugin has sold the most Bristol-Myers Squibb Company stock with a total value of $90,990,863.06.
Corp /De/ Celgene has bought the most Bristol-Myers Squibb Company stock with a total value of $22,404,200.00.
The most recent insider trade for Bristol-Myers Squibb Company was on Aug. 2, 2025.
The single biggest insider buy for Bristol-Myers Squibb Company was from Corp /De/ Celgene with a total value of $11,202,100.00 on Oct. 24, 2016.
The single biggest insider sell for Bristol-Myers Squibb Company was from Robert J Hugin with a total value of $23,604,615.80 on June 22, 2017.